210 related articles for article (PubMed ID: 21782251)
1. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.
Kemp DE; Ismail-Beigi F; Ganocy SJ; Conroy C; Gao K; Obral S; Fein E; Findling RL; Calabrese JR
J Affect Disord; 2012 Feb; 136(3):1164-73. PubMed ID: 21782251
[TBL] [Abstract][Full Text] [Related]
2. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.
Kemp DE; Schinagle M; Gao K; Conroy C; Ganocy SJ; Ismail-Beigi F; Calabrese JR
CNS Drugs; 2014 Jun; 28(6):571-81. PubMed ID: 24715548
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
Aftab A; Kemp DE; Ganocy SJ; Schinagle M; Conroy C; Brownrigg B; D'Arcangelo N; Goto T; Woods N; Serrano MB; Han H; Calabrese JR; Gao K
J Affect Disord; 2019 Feb; 245():957-964. PubMed ID: 30699881
[TBL] [Abstract][Full Text] [Related]
4. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
Kashani L; Omidvar T; Farazmand B; Modabbernia A; Ramzanzadeh F; Tehraninejad ES; Ashrafi M; Tabrizi M; Akhondzadeh S
Psychoneuroendocrinology; 2013 Jun; 38(6):767-76. PubMed ID: 22999261
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.
Zeinoddini A; Sorayani M; Hassanzadeh E; Arbabi M; Farokhnia M; Salimi S; Ghaleiha A; Akhondzadeh S
Depress Anxiety; 2015 Mar; 32(3):167-73. PubMed ID: 25620378
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response.
Lin KW; Wroolie TE; Robakis T; Rasgon NL
Psychiatry Res; 2015 Dec; 230(3):846-52. PubMed ID: 26602230
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.
Kemp DE; Ismail-Beigi F; Calabrese JR
Am J Psychiatry; 2009 May; 166(5):619. PubMed ID: 19411385
[No Abstract] [Full Text] [Related]
8. Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.
Sepanjnia K; Modabbernia A; Ashrafi M; Modabbernia MJ; Akhondzadeh S
Neuropsychopharmacology; 2012 Aug; 37(9):2093-100. PubMed ID: 22549115
[TBL] [Abstract][Full Text] [Related]
9. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort).
Singh S; Bhansali A
BMC Dermatol; 2016 Aug; 16(1):12. PubMed ID: 27531132
[TBL] [Abstract][Full Text] [Related]
12. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
14. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.
Lopresti AL; Maes M; Maker GL; Hood SD; Drummond PD
J Affect Disord; 2014; 167():368-75. PubMed ID: 25046624
[TBL] [Abstract][Full Text] [Related]
15. Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study.
Dichtel LE; Nyer M; Dording C; Fisher LB; Cusin C; Shapero BG; Pedrelli P; Kimball AS; Rao EM; Mischoulon D; Fava M; Miller KK
J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32558402
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study.
Hobart M; Skuban A; Zhang P; Josiassen MK; Hefting N; Augustine C; Brewer C; Sanchez R; McQuade RD
Curr Med Res Opin; 2018 Apr; 34(4):633-642. PubMed ID: 29343128
[TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
Smith RC; Jin H; Li C; Bark N; Shekhar A; Dwivedi S; Mortiere C; Lohr J; Hu Q; Davis JM
Schizophr Res; 2013 Jan; 143(1):18-24. PubMed ID: 23200554
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.
Vu A; Kosmiski LA; Beitelshees AL; Prigeon R; Sidhom MS; Bredbeck B; Predhomme J; Deininger KM; Aquilante CL
Pharmacotherapy; 2016 Mar; 36(3):252-62. PubMed ID: 26822630
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial.
Calabrese JR; Frye MA; Yang R; Ketter TA;
J Clin Psychiatry; 2014 Oct; 75(10):1054-61. PubMed ID: 25099397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
